{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:04:04Z","timestamp":1793747044570,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019139","name":"Life Sciences, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100027043","name":"Milken Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022974","name":"Global Alliance for Chronic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022974","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbih.2025.101166","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:25:25Z","timestamp":1766420725000},"page":"101166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Neuroinflammation and insulin resistance in major depression and bipolar disorder: Implications for clinical trials evaluating immunometabolic targeted therapies"],"prefix":"10.1016","volume":"51","author":[{"given":"Folkert H.","family":"van Bruggen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbih.2025.101166_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jad.2018.11.090","article-title":"Double-blind, placebo-controlled trial of pioglitazone for bipolar depression","volume":"245","author":"Aftab","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbih.2025.101166_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2022.100551","article-title":"Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial","volume":"26","author":"Aichholzer","year":"2022","journal-title":"Brain, Behavior, & Immunity - Health"},{"key":"10.1016\/j.bbih.2025.101166_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pnpbp.2018.05.017","article-title":"Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders","volume":"86","author":"Alageel","year":"2018","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"7","key":"10.1016\/j.bbih.2025.101166_bib4","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3390\/biomedicines12071493","article-title":"The Triglyceride\/HDL ratio as a surrogate biomarker for insulin resistance","volume":"12","author":"Baneu","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbih.2025.101166_bib5","series-title":"Inflammation as a Mechanism of Bipolar Disorder Neuroprogression","first-page":"215","author":"Barichello","year":"2020"},{"key":"10.1016\/j.bbih.2025.101166_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172838","article-title":"Efficacy of infliximab in treatment-resistant depression: a systematic review and meta-analysis","volume":"188","author":"Bavaresco","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.bbih.2025.101166_bib7","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14022","article-title":"Treating insulin resistance with metformin as a strategy to improve clinical outcomes in treatment-resistant bipolar depression (the TRIO-BD study)","volume":"83","author":"Calkin","year":"2022","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbih.2025.101166_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2174\/1566524016666160429121737","article-title":"Repurposing of anti-diabetic agents for the treatment of cognitive impairment and mood disorders","volume":"16","author":"Cha","year":"2016","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.bbih.2025.101166_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/NDT.S121149","article-title":"Pioglitazone could induce remission in major depression: a meta-analysis","volume":"13","author":"Colle","year":"2016","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"3","key":"10.1016\/j.bbih.2025.101166_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249409","article-title":"Statins for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"De Giorgi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbih.2025.101166_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbi.2025.05.011","article-title":"Blood immuno-metabolic biomarker signatures of depression and affective symptoms in young adults","volume":"128","author":"Donnelly","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2025.101166_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.981442","article-title":"Meta-analysis of molecular imaging of translocator protein in major depression","volume":"15","author":"Eggerstorfer","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbih.2025.101166_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue","volume":"81","author":"Enache","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.bbih.2025.101166_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/bdi.13104","article-title":"Inflammation and disease modification in bipolar disorders: priority avenues for future research","volume":"23","author":"Gill","year":"2021","journal-title":"Bipolar Disord."},{"issue":"8","key":"10.1016\/j.bbih.2025.101166_bib14","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4088\/JCP.08r04505","article-title":"Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder","volume":"70","author":"Goldstein","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbih.2025.101166_bib15","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1038\/s41598-022-10350-5","article-title":"Association between lipid ratio and depression: a cross-sectional study","volume":"12","author":"Han","year":"2022","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bbih.2025.101166_bib16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/biomedicines9101428","article-title":"Exosomal let-7e, miR-21-5p, miR-145, miR-146a and miR-155 in predicting antidepressants response in patients with major depressive disorder","volume":"9","author":"Hung","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.bbih.2025.101166_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S1092852922001043","article-title":"The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia","volume":"28","author":"Jawad","year":"2023","journal-title":"CNS Spectr."},{"key":"10.1016\/j.bbih.2025.101166_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106203","article-title":"The overlooked role of metabolic disorders in bipolar disorder","volume":"174","author":"Khayachi","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.bbih.2025.101166_bib19","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects","volume":"71","author":"K\u00f6hler","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.bbih.2025.101166_bib20","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s43440-024-00621-5","article-title":"Insulin resistance, clinical presentation and resistance to selective serotonin and noradrenaline reuptake inhibitors in major depressive disorder","volume":"76","author":"Krupa","year":"2024","journal-title":"Pharmacol. Rep."},{"issue":"7","key":"10.1016\/j.bbih.2025.101166_bib22","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1038\/s41380-021-01051-y","article-title":"Peripheral inflammatory biomarkers define biotypes of bipolar depression","volume":"26","author":"Lee","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"12","key":"10.1016\/j.bbih.2025.101166_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/2045125318791944","article-title":"Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression","volume":"8","author":"Lee","year":"2018","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"1","key":"10.1016\/j.bbih.2025.101166_bib24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12888-024-05838-5","article-title":"Prevalence of insulin resistance and its associated factors in drug-na\u00efve patients with bipolar disorder among han Chinese population","volume":"24","author":"Li","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbih.2025.101166_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jad.2021.12.110","article-title":"Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: a systematic review and meta-analysis","volume":"300","author":"Liu","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbih.2025.101166_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.euroneuro.2025.02.009","article-title":"Extracellular vesicles in mood disorders: a systematic review of human studies","volume":"94","author":"Llach","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.bbih.2025.101166_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/cells9040895","article-title":"Extracellular vesicle biomarkers reveal inhibition of neuroinflammation by infliximab in association with antidepressant response in adults with bipolar depression","volume":"9","author":"Mansur","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbih.2025.101166_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jad.2020.11.128","article-title":"Effects of infliximab on brain neurochemistry of adults with bipolar depression","volume":"281","author":"Mansur","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.bbih.2025.101166_bib31","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.euroneuro.2017.08.433","article-title":"Treatment with a GLP\u22121R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders","volume":"27","author":"Mansur","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.bbih.2025.101166_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1176\/appi.ajp.2021.21080814","article-title":"Surrogate markers of insulin resistance in predicting major depressive disorder: metabolism metastasizes to the brain","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatr."},{"issue":"10265","key":"10.1016\/j.bbih.2025.101166_bib33","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbih.2025.101166_bib34","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1017\/S1092852925000124","volume":"30","author":"McIntyre","year":"2025","journal-title":"CNS Spectr."},{"issue":"5","key":"10.1016\/j.bbih.2025.101166_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S1092852918001670","article-title":"Does obesity and diabetes mellitus metastasize to the brain? \u201cMetaboptosis\u201d and implications for drug discovery and development","volume":"24","author":"McIntyre","year":"2019","journal-title":"CNS Spectr."},{"issue":"12","key":"10.1016\/j.bbih.2025.101166_bib62","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/dc08-0985","article-title":"Depression and Type 2 Diabetes Over the Lifespan","volume":"31","author":"Mezuk","year":"2008","journal-title":"Diabetes Care."},{"key":"10.1016\/j.bbih.2025.101166_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2023.04.068","article-title":"Insulin resistance in bipolar disorder: a systematic review of illness course and clinical correlates","volume":"334","author":"Miola","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.bbih.2025.101166_bib61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jamapsychiatry.2022.0645","article-title":"Cerebrospinal Fluid Biomarkers in Patients With Unipolar Depression Compared With Healthy Control Individuals","volume":"79","author":"Mousten","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.bbih.2025.101166_bib38","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1038\/s41380-020-0804-7","article-title":"Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance","volume":"26","author":"Nasca","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.bbih.2025.101166_bib39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jad.2022.04.156","article-title":"Investigating the pro-cognitive and anti-depressant efficacy of metformin: a systematic review and meta-analysis of randomised controlled trials","volume":"310","author":"Nibber","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbih.2025.101166_bib40","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls","volume":"87","author":"Osimo","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2025.101166_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105325","article-title":"Inflammation in Bipolar Disorder (BD): identification of new therapeutic targets","volume":"163","author":"Pereira","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbih.2025.101166_bib42","article-title":"A peripheral inflammatory signature discriminates bipolar from unipolar depression: a machine learning approach","volume":"105","author":"Poletti","year":"2021","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"6","key":"10.1016\/j.bbih.2025.101166_bib43","doi-asserted-by":"crossref","first-page":"959","DOI":"10.17305\/bjbms.2022.7110","article-title":"Serum extracellular vesicle microRNA dysregulation and childhood trauma in adolescents with major depressive disorder","volume":"22","author":"Ran","year":"2022","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"7","key":"10.1016\/j.bbih.2025.101166_bib44","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/biomedicines10071582","article-title":"Insulin resistance in peripheral tissues and the brain: a tale of two sites","volume":"10","author":"Rhea","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.bbih.2025.101166_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/bdi.12373","article-title":"Anti\u2010inflammatory agents in the treatment of bipolar depression: a systematic review and meta\u2010analysis","volume":"18","author":"Rosenblat","year":"2016","journal-title":"Bipolar Disord."},{"issue":"01","key":"10.1016\/j.bbih.2025.101166_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4088\/JCP.12r07922","article-title":"Depression as a Risk Factor for Diabetes","volume":"74","author":"Rotella","year":"2013","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.bbih.2025.101166_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mito.2020.12.002","article-title":"Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder","volume":"57","author":"Scaini","year":"2021","journal-title":"Mitochondrion"},{"issue":"3","key":"10.1016\/j.bbih.2025.101166_bib47","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","article-title":"Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes","volume":"72","author":"Setiawan","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bbih.2025.101166_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pnpbp.2018.01.003","article-title":"Targeting cytokines in reduction of depressive symptoms: a comprehensive review","volume":"83","author":"Shariq","year":"2018","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.bbih.2025.101166_bib49","article-title":"Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment","volume":"104","author":"Siegel","year":"2021","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.bbih.2025.101166_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00406-022-01412-w","article-title":"Canonical insulin signaling is not significantly impaired in early stages of depression","volume":"273","author":"Singh","year":"2023","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.bbih.2025.101166_bib51","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/schbul\/sbab010","article-title":"Simvastatin augmentation for patients with early-phase schizophrenia-spectrum disorders: a Double-Blind, randomized placebo-controlled trial","volume":"47","author":"Sommer","year":"2021","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.bbih.2025.101166_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.31887\/DCNS.2017.19.1\/rmcintyre","article-title":"Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders","volume":"19","author":"Subramaniapillai","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"issue":"18","key":"10.1016\/j.bbih.2025.101166_bib53","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000042337","article-title":"Association between TG\/HDL-C and depression in US adults: a nationally representative cross-sectional study","volume":"104","author":"Tang","year":"2025","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.bbih.2025.101166_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1055\/a-1882-8423","article-title":"A systematic review and meta-analysis of Metabolic syndrome prevalence in Chinese inpatients with bipolar disorder","volume":"54","author":"Tao","year":"2022","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/j.bbih.2025.101166_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2012.12050620","article-title":"Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators","volume":"170","author":"Vancampfort","year":"2013","journal-title":"Am. J. Psychiatr."},{"issue":"10","key":"10.1016\/j.bbih.2025.101166_bib56","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1176\/appi.ajp.2021.20101479","article-title":"Incident Major depressive disorder predicted by three measures of insulin resistance: a Dutch cohort Study","volume":"178","author":"Watson","year":"2021","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbih.2025.101166_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbi.2022.12.014","article-title":"Hyper-inflammation of astrocytes in patients of major depressive disorder: evidence from serum astrocyte-derived extracellular vesicles","volume":"109","author":"Xie","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.bbih.2025.101166_bib58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/pcn.13596","article-title":"Human in vivo evidence of reduced astrocyte activation and neuroinflammation in patients with treatment\u2010resistant depression following electroconvulsive therapy","volume":"77","author":"Xu","year":"2023","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.bbih.2025.101166_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2024.02.011","article-title":"Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia","volume":"266","author":"Zaki","year":"2024","journal-title":"Schizophr. Res."}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354625002248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354625002248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:19:37Z","timestamp":1773922777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354625002248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":59,"alternative-id":["S2666354625002248"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2025.101166","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroinflammation and insulin resistance in major depression and bipolar disorder: Implications for clinical trials evaluating immunometabolic targeted therapies","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2025.101166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101166"}}